文献速递骨质疏松与代谢性骨病创伤骨科

一例长期接受双膦酸盐治疗的骨质疏松患者发生颌骨坏死与不典型股骨骨折

Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates.
PubMed 文献 · Osteoporos Int · 2016-11-20

报告一例87岁意大利裔女性骨质疏松患者,长期接受双膦酸盐治疗后同时发生颌骨坏死和不典型股骨骨折。原文指出,虽然颌骨坏死与不典型股骨骨折的关联在高剂量双膦酸盐治疗的癌症患者中已知,但在常规剂量治疗的骨质疏松患者中非常罕见,此前仅报告过三例,均为东方女性,本例似乎是首例白人女性病例。

要点

  • 87岁女性骨质疏松患者,长期使用阿仑膦酸钠和唑来膦酸后发生颌骨坏死和不典型股骨骨折。
  • 原文指出,颌骨坏死与不典型股骨骨折的关联在常规剂量双膦酸盐治疗的骨质疏松患者中非常罕见。
  • 此前仅报告过三例此类病例,均为东方女性,本例似乎是首例白人女性病例。

核心结论

  • 长期双膦酸盐治疗的骨质疏松患者中,颌骨坏死与不典型股骨骨折的关联非常罕见;此前仅报告过三例,均为东方女性,本例似乎是首例白人女性病例。

研究设计与样本

  • 病例报告:一例87岁意大利裔女性骨质疏松患者,1999—2006年每周口服阿仑膦酸钠7年,2006—2008年每年静脉注射唑来膦酸5 mg共3年。

主要发现

  • 患者2009年跌倒后发生左股骨转子下骨折,手术恢复顺利;2012年因牙齿松动拔除磨牙并佩戴假牙后,下颌牙龈溃疡暴露骨质2个月不愈,影像学诊断为颌骨坏死,经手术清创和局部及全身抗生素治疗后好转。
  • 2013年初实验室检查除血清甲状旁腺激素(PTH)和I型胶原C端肽(CTX-I)轻度升高外均正常;予骨化三醇0.25 mcg/天,3个月后血清钙、磷、PTH和CTX-I无变化。
  • 两年后跌倒后急性下背痛,MRI显示D12新近压缩性骨折及D11和L1陈旧性畸形;右髋骨密度(DXA)股骨颈T值为-2.3;右股骨X线片显示双侧皮质弥漫性增厚。
  • 予鼻喷降钙素和镇痛药治疗,背痛缓解后予皮下注射地舒单抗。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The aim of the study is to report the rare association of two complications of long-term treatment of osteoporosis with bisphosphonates in the same Caucasian elderly patient. A female patient of Italian descent, age 87 years, consulted in February 2013. She had a history of osteoporosis and had taken alendronate weekly for 7 years (1999-2006). Due to low back pain, an orthopedist had indicated i.v. zoledronic acid, 5 mg/year for 3 years (2006-2008). She received occasional supplements of ergocalciferol. In 2009, she suffered a fall and sustained a subtrochanteric fracture of the left femur. She was operated on and recovered uneventfully. In 2012, she consulted a dentist due to loose teeth. She underwent the removal of a molar and was given a denture. She had discomfort when using the prosthesis, and developed an ulceration in the gum of the mandible, which exposed the bone and did not heal for 2 months. After radiologic studies, the diagnosis was osteonecrosis of the jaw. She improved after surgical debridement and local and systemic antibiotics. In early 2013, laboratory tests were normal except for a slight elevation of serum PTH and CTX-I. Calcitriol 0.25 mcg/day was prescribed; after 3 months serum calcium, phosphate, PTH, and CTX-I showed no variation. Two years later, she experienced acute low back pain after a fall; MRI showed recent crushing of D12, and chronic deformities of D11 and L1. Bone densitometry of her right hip (DXA) showed a T-score of -2.3 at the femoral neck. An X-ray film of the right femur showed diffuse thickening of both cortices. She was treated with nasal calcitonin and analgesics. After the back pain subsided, she was treated with s.c. denosumab. Although the association of ONJ and AFF was known in cancer patients treated with high doses of bisphosphonates, it is very rare in patients with osteoporosis receiving these drugs at usual doses. Only three cases have been reported, all in oriental women. This appears to be the first reported case in a Caucasian woman.

来源:Osteoporos Int,查看原文。版权归原作者所有。

引用

  1. Sánchez A, Blanco R. Osteonecrosis of the jaw (ONJ) and atypical femoral fracture (AFF) in an osteoporotic patient chronically treated with bisphosphonates. Osteoporos Int. 2016. PMID: 27866217. doi:10.1007/s00198-016-3840-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。